Cancer News

In a notable achievement for the UCLA community, two researchers have been elected to the National Academy of Inventors, highlighting their significant contributions to both cancer treatment and...

Recent research published in JAMA Internal Medicine has stirred discussions in the oncology community about the future of genetic testing for breast cancer risk. The study reveals that many women who...

The recent publication of the WISDOM (Women Informed to Screen Depending On Measures of risk) trial results has sparked significant discussion within the oncology community. This study aimed to...

Recent advancements in cancer research are transforming the way medical professionals approach pancreatic cancer, one of the most challenging malignancies to treat. A new tool called the Tianjin...

Pancreatic cancer remains one of the most challenging malignancies to treat, with limited tools available for accurate prognosis. Recent developments in the Tianjin Grading System offer a promising...

In a significant advancement for oncology, histotripsy has emerged as a novel treatment for liver tumors, demonstrating promising results in local tumor control and preliminary oncologic efficacy....

Recent advances in neuro-oncology have spotlighted focused ultrasound (FUS) as a promising tool for diagnosing and treating aggressive brain tumors. This innovative technology offers a non-invasive...

Recent advancements in cancer treatment have led to the exploration of High-Intensity Focused Ultrasound (HIFU) as a potential therapy for renal cell carcinoma (RCC), particularly in patients...

The recent announcement from the Trump administration regarding new regulations for cancer registries has raised significant concerns among LGBTQ+ health advocates and researchers. Starting in 2026,...

Recent advancements in breast cancer treatment were highlighted at the San Antonio Breast Cancer Symposium (SABCS), where researchers unveiled promising findings about giredestrant, a next-generation...

The landscape of breast cancer treatment is evolving with the introduction of AidaBreast™, a groundbreaking multi-omic test designed to accurately predict locoregional recurrence risk and assess the...

In a promising development for oncology, Novastra Therapeutics has initiated a Phase 1b clinical trial for OAP-1, a novel immune reprogramming cancer therapy aimed at patients with advanced solid...

Recent developments in cancer treatment have shed light on an innovative immunotherapy, OAP-1, being tested by Novastra Therapeutics. This novel approach has shown promising early results in patients...

Recent advancements in artificial intelligence (AI) are set to transform the landscape of cancer detection, particularly in gastrointestinal cancers. Researchers from Chulalongkorn University have...

The San Antonio Breast Cancer Symposium (SABCS) 2025 is set to showcase groundbreaking research from Roswell Park Comprehensive Cancer Center, where a diverse group of experts will present their...

Researchers at The University of Texas MD Anderson Cancer Center have unveiled a groundbreaking antibody therapy known as 77A, presenting a significant advancement in the battle against...

Recent findings presented at the American Society of Hematology (ASH) annual meeting highlight a groundbreaking antibody therapy that may significantly advance the treatment of multiple myeloma, a...

Recent developments in cancer treatment continue to inspire hope, particularly for patients battling difficult forms of the disease. At the 67th American Society of Hematology (ASH) Annual Meeting,...

Recent research presented at the 2025 American Society of Hematology (ASH) meeting has unveiled groundbreaking insights into how the structure of DNA within our cells can influence the onset of...

Recent findings from the ACCESS trial have revealed a significant breakthrough in the field of stem cell transplantation for patients with blood cancers, such as leukemia. Traditionally, successful...